Takeda

Takeda launches 'first-of-its-kind' global observational study

Multiple myeloma is a rare form of cancer, with approximately 114,000 new cases globally per year. (Image: iStock/BernardaSv)

The open-source study was launched in order to advance understanding of real-world experience with therapies and clinical outcomes in patients with multiple myeloma.

Research consortium looks to identify biomarkers for autism treatments

Research consortium looks to identify biomarkers for autism treatments

Takeda looks to BioXcel to help repurpose old assets for new rare disease indications

Takeda looks to BioXcel to help repurpose old assets for new rare disease indications

Brian Cass, Huntingdon CEO

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

CMO opportunities as Russia embraces its Pharma 2020 strategy

Russia set for first foreign CMOs as pharma preps for 2020 policy

Lonza adding single-use systems at its clinical ADC facility in Visp, Switzerland

ADC pipelines drive single-use expansion at Lonza's clinical facility

Record year for contract sales, but no end to AMRI's ambition

AMRI to focus on scale and capabilities of API biz following robust 2013

AMEC to expand pharma plant design biz with $3bn Foster Wheeler buy

AMEC to expand pharma plant design biz with $3bn Foster Wheeler buy

Competition not a concern says Carbogen Amcis CEO

Carbogen Amcis CEO: Competition in ADC sector not a concern

Pfizer Selects Sanford-Burnham for Diabetes Drug Discovery

Pfizer Selects Sanford-Burnham for Diabetes Drug Discovery

More Takeda